Is Sunosi (solriamfetol) a controlled substance?
Medically reviewed by Drugs.com. Last updated on Sep 10, 2019.
Yes. Sunosi (solriamfetol) is a Schedule IV Controlled Substance in the United States.
Sunosi (solriamfetol) is a selective dopamine and norepinephrine reuptake inhibitor (DNRI) for the treatment of excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA). It was approved by the FDA in March 2019.
Sunosi is a federally controlled substance (CIV) because it contains solriamfetol, which has the potential for abuse.
Sunosi should always be stored in a safe place to protect it from theft. Any unused or expired Sunosi should be disposed of via a medication take-back program, or mixed with an undesirable substance and thrown away in the household trash.
Related Medical Questions
- Modafinil vs Adderall: What's the difference?
- Focalin vs Adderall: What's the difference?
- Ritalin vs Vyvanse - What's the difference between them?
- What exactly is Captagon and why was it banned?
- What are the brands of methylphenidate?
- Is Adzenys XR-ODT the same as Adderall XR?
- Is Wakix a controlled substance?
- How does Wakix work for narcolepsy?
- Can any doctor prescribe Xyrem?
- Is Xyrem a controlled substance / narcotic drug of abuse?
- Can you take Xyrem while pregnant?